Anti-Pan-FHF-A [N235/22R] Citations (2)

Originally described in: A toolbox of IgG subclass-switched recombinant monoclonal antibodies for enhanced multiplex immunolabeling of brain.
Andrews NP, Boeckman JX, Manning CF, Nguyen JT, Bechtold H, Dumitras C, Gong B, Nguyen K, van der List D, Murray KD, Engebrecht J, Trimmer JS eLife. 2019 Jan 22;8. pii: 43322. doi: 10.7554/eLife.43322. PubMed Journal

---

Articles Citing Anti-Pan-FHF-A [N235/22R]

Articles
Ceramide-induced FGF13 impairs systemic metabolic health. Naderi J, Johnson AK, Thakkar H, Chandravanshi B, Ksiazek A, Anand A, Vincent V, Tran A, Kalimireddy A, Singh P, Sood A, Das A, Talbot CL, Distefano IA, Maschek JA, Cox J, Li Y, Summers SA, Atkinson DJ, Turapov T, Ratcliff JA, Fung J, Shabbir A, Shabeer Yassin M, Shiow STE, Holland WL, Pitt GS, Chaurasia B. Cell Metab. 2025 May 6;37(5):1206-1222.e8. doi: 10.1016/j.cmet.2025.03.002. Epub 2025 Mar 31. PubMed
FGF13 is not secreted from mouse neurons. Malvezzi M, Zhang H, Towers P, Lyden DC, Marx SO, Pitt GS. JCI Insight. 2025 Nov 25;11(1):e195998. doi: 10.1172/jci.insight.195998. eCollection 2026 Jan 9. PubMed

If you have published an article using this material, please email us at to have your article added to this page.